title: Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
authors.affiliation: Department of Pediatrics, UKSH, Campus Lübeck, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Lauten
authors.affiliation: Department of Pediatrics, HELIOS Kliniken Schwerin, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Güttel
authors.affiliation: Department of Pediatrics, UKSH, Campus Lübeck, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Härtel
authors.affiliation: Department of Pediatrics, Mühlenkreiskliniken, Minden, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Erdlenbruch
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000139:chemically induced; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use; D020803:Encephalitis, Herpes Simplex / Q000139:chemically induced / Q000175:diagnosis; D017809:Fatal Outcome; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006561:Herpes Simplex / Q000139:chemically induced* / Q000821:virology; D006801:Humans; D060828:Induction Chemotherapy; D007223:Infant; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000821:virology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D018139:Simplexvirus / Q000187:drug effects*; D013283:Stomatitis, Herpetic / Q000139:chemically induced / Q000821:virology; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin